Search clinical trials for: Infliximab and MTX

Total 272498 results

Assiut University

Not yet recruiting

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

Inflammatory Bowel Diseases | Bowel Disease
Pfizer

Completed

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease (ONWARD)

Inflammatory Bowel Disease (IBD) | Ulcerative Colitis (UC) | Crohn's Disease (CD)

United States, Canada
Samsung Medical Center

Completed

Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy

Crohn's Disease

Korea, Republic of
Centocor, Inc.

Completed

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

Ulcerative Colitis
Centocor, Inc.

Completed

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

Chronic Obstructive Pulmonary Disease | COPD
Swiss EE Study Group

Completed

Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis (IEE)

Esophagitis

Switzerland
Charite University, Berlin, Germany
dfg

Unknown

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Reactive Arthritis

Germany
Carmel Medical Center

Unknown

Anti TNF α Improves Endothelial Dysfunction in IBD Patients

Crohn's Disease

Israel
Guang'anmen Hospital of China Academy of Chinese...

Unknown

A Specification Clinical Application Research of Tripterygium Wilfordii Treating Rheumatoid Arthritis

Rheumatoid Arthritis

China
Asan Medical Center

Completed

Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

Crohn's Disease | Ulcerative Colitis

Korea, Republic of
Gilead Sciences
Galapagos NV

Completed

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy (FINCH 3)

Rheumatoid Arthritis

United States, Italy, Poland, Ukraine, Belgium, Hong Kong, Taiwan, Spain, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Korea, Republic of, Japan, Australia, Chile, Russian Federation, Argentina, Germany, New Zealand, Th... and more
University of Alberta
The Hospital for Sick Children; Children's Hospital of Eastern Ontario; Alberta... and other collaborators

Completed

IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study (IDeaL)

Crohn's Disease | Inflammatory Bowel Disease

Canada
Ospedale San Raffaele

Unknown

Infliximab Biosimilar in Takayasu's Arteritis (TAKASIM)

Takayasu Arteritis

Italy
Novartis Pharmaceuticals

Completed

A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients

Crohn's Disease

Germany, Switzerland
Celltrion

Completed

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Rheumatoid Arthritis

Korea, Republic of
Centocor, Inc.

Completed

A Study of Infliximab in Patients With Sarcoidosis

Sarcoidosis
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Stop Infliximab in Patients With Crohn's Disease (STORI)

Crohn Disease

France, Belgium
Janssen Research & Development, LLC

Completed

A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

Arthritis, Rheumatoid

Poland, Ukraine, Colombia, Bulgaria, United States, Singapore, Russian Federation, Argentina, Hungary, Chile, Czech Republic
Hoffmann-La Roche

Completed

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Rheumatoid Arthritis

China
Copenhagen University Hospital at Herlev

Completed

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission (STOP IT)

Crohn Disease

Sweden, Denmark, Finland, Norway
Celltrion

Completed

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Crohn's Disease | Ulcerative Colitis (Part 2 Only)

Korea, Republic of
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease

Pediatric Crohn's Disease

Japan
Grupo de Estudo da Doença Inflamatória Intestinal

Completed

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis (HERICA)

Ulcerative Colitis

Portugal
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Crohn's Disease

Japan
Hospital de Clinicas de Porto Alegre

Unknown

Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease

Graft vs Host Disease

Brazil
Oslo University Hospital

Completed

Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease

Norway
Celltrion

Completed

A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

Rheumatoid Arthritis

Korea, Republic of
Maier, Lisa, M.D.
Centocor, Inc.; National Center for Research Resources (NCRR)

Terminated

Beryllium Infliximab Study: Clinical Interventional Trial (BISCIT)

Berylliosis | Beryllium Disease

United States
Comprehensive Support Project for Oncology Research

Completed

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (RESPECT)

Breast Cancer

Japan
Academisch Medisch Centrum - Universiteit van Amsterdam...
Pfizer

Recruiting

TITRATE (inducTIon for acuTe ulceRATivE Colitis) (TITRATE)

Colitis, Ulcerative

Netherlands, Ireland, Norway
Ain Shams University
Misr International University

Completed

Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

Covid19 | Corona Virus Infection | Cytokine Storm

Egypt
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)

Spondylitis, Ankylosing
Fudan University
Shanghai 10th People's Hospital; Shanghai Children's Medical Center; Shanghai... and other collaborators

Completed

Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial

Kawasaki Disease

China
National Institute of Allergy and Infectious Diseases...

Terminated

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

Chronic Granulomatous Disease | Inflammatory Bowel Disease (IBD) | Crohn'S-like IBD

United States
Merck Sharp & Dohme LLC

Completed

Assessment of Long-Term Infliximab for Psoriasis (P05319) (REALITY)

Psoriasis
Merck Sharp & Dohme LLC

Completed

Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Terminated

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

Crohn Disease
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study of NI-071

Healthy

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

Rheumatoid Arthritis

United States, Czechia, Poland, Puerto Rico, Russian Federation, Spain, Ukraine, United Kingdom
Children's Hospital of Fudan University

Withdrawn

Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients

Crohn's Disease | Exclusive Enteral Nutrition | Infliximab | Mucosal Healing
Merck Sharp & Dohme LLC

Completed

Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) (ESAQUALITY)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (TIPS)

Psoriasis
Merck Sharp & Dohme LLC

Completed

A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) (REQUEST)

Rheumatoid Arthritis
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Psoriasis
Merck Sharp & Dohme LLC
Hospital Universitario Reina Sofia de Cordoba; Dr. Jose María Martos Becerra...

Withdrawn

Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) (HACER)

Ankylosing Spondylitis
Innovaderm Research Inc.
Schering-Plough

Completed

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Palmoplantar Psoriasis

Canada
University Hospital, Gentofte, Copenhagen
Pfizer; The Michaelsen Foundation

Unknown

TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

Psoriasis

Denmark, Sweden

3

Subscribe